FACTORS INVOLVED IN THE STABILITY OF PERTUSSIS COMPONENT IN QUADRUPLE DPT-POLIO VACCINE.
D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local; D004168:Diphtheria Toxoid; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D006801:Humans; D009113:Muramidase; D010447:Peptide Hydrolases; D010567:Pertussis Vaccine; D011051:Poliomyelitis; D023321:Poliovirus Vaccines; D000644:Quaternary Ammonium Compounds; D013745:Tetanus Toxoid; D014917:Whooping Cough
D064751:Ammonium Compounds; D000891:Anti-Infective Agents, Local; D004168:Diphtheria Toxoid; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D010567:Pertussis Vaccine; D023321:Poliovirus Vaccines; D000644:Quaternary Ammonium Compounds; D013745:Tetanus Toxoid; D009113:Muramidase; D010447:Peptide Hydrolases
ANTISEPTICS, QUATERNARY AMMONIUM; DIPHTHERIA TOXOID; MURAMIDASE; PEPTIDE HYDROLASES; PERTUSSIS VACCINE; POLIOVIRUS VACCINE; TETANUS TOXOID